http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110711198-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_653c418e41edbb4e1ce8bc5e53e70cec
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
filingDate 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17ba2e55dccd99087392a182ae92f3a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd78e5c60d6b235518d7753da43939d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f03a7c048551be1e2522604ae510a6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21e44c422ca347e2ebf66fa41e1c9901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93ec558c6f6e744c2015a317d7c3e361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c48186d66e51dfd9862dc62e6fcf4e4d
publicationDate 2020-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110711198-A
titleOfInvention Application of D-mannose in the preparation of antidepressant drugs
abstract The invention discloses the antidepressant activity of D-mannose, which can be used for preparing antidepressant drugs and health care products. Through animal modeling experiments, animal behavioral experiments and in vitro experiments. For the first time, it was verified that D-mannose can alleviate depression-related behaviors, fight anxiety, and significantly reduce the levels of neurotransmitters in the hippocampus, hypothalamus, and prefrontal lobes of mouse brains. Based on the good antidepressant activity of D-mannose, the present invention correspondingly protects the application of D-mannose in the preparation of antidepressant drugs and health care products, and provides a pharmaceutical composition with antidepressant effect, an antidepressant Depression medication and an antidepressant supplement.
priorityDate 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005075928-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101189220-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13750
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65127
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456490753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18950

Total number of triples: 39.